Denosumab Drug Substance from China
Denosumab Drug Substance is a RANKL inhibitor monoclonal antibody for osteoporosis and cancer bone metastases. It is an unmixed immunological product, not in measured doses or retail packs, and is classified under 3002.13.00.
Duty Rate — China → Canada
0%
Import Tips
• Verify the product is unmixed and in bulk form
• Provide certificates of analysis to CBSA
• Confirm if a Health Canada import permit is needed for the drug substance